GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast Cancer
Qin Wu(Chinese Academy of Sciences), C.H. Arrowsmith(University Health Network), Benjamin Haibe‐Kains(University of Toronto), Seyed Ali Madani Tonekaboni(University Health Network), Jennifer Cruickshank(Ontario Institute for Cancer Research), Jillian Haight(University Health Network), Susan J. Done(University Health Network), Ravi N. Vellanki(University Health Network), Shili Duan(Ontario Institute for Cancer Research), Evelyne Lima‐Fernandes(University of Toronto), Nergiz Doğan(University Health Network), Wail Ba-Alawi(King Abdullah University of Science and Technology), Stanley Zhou(University Health Network), David W. Cescon(Princess Margaret Hospital), Anne-Marie Fortier(McGill University Health Centre), Hassan Mahmoud(University Health Network), Geneviève Deblois(Institute for Research in Immunology and Cancer), Morag Park(McGill University Health Centre), Trevor D. McKee(University Health Network), Wenjun Chen(University of Toronto), Sarina Cameron(University Health Network), Hellen Kuasne(McGill University Health Centre), Mathieu Lupien(Ontario Institute for Cancer Research)
Cited by 19
Related Papers
Epigenetic protein families: a new frontier for drug discovery
|Nature Reviews Drug Discovery|2012|1.3k
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848